TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

International Journal of Advances In Case Reports

Volume 11, Issue 1, 2024
Mcmed International
International Journal of Advances In Case Reports
Issn
XXX-XXXX (Print), 2349 - 8005 (Online)
Frequency
bi-annual
Email
editorijacr@mcmed.us
Journal Home page
http://mcmed.us/about/ijacr
Recommend to
Purchase
Abstract
Title
SEVERE SKIN RASH WITH LAMIVUDINE IN HIV INFECTED PATIENTS; SOME UNUSAL CASE REPORTS
Author
SEVERE SKIN RASH WITH LAMIVUDINE IN HIV INFECTED PATIENTS; SOME UNUSAL CASE REPORTS
Email
nancykavyamanuel19@gmail.com
keyword
Antiretroviral Therapy, HIV, Adverse Drug Reaction
Abstract
With an alarming increase in the incidence of Human immunodeficiency virus (HIV) infections, use of antiretroviral drugs has been playing a vital role in improving quality of life and disease-related condition of these patients. HIV-infected patients are at an increased risk of developing mucocutaneous drug reaction. Nearly 80% patients experienced adverse drug reaction at some time during treatment either from immune dysregulation or altered drug metabolism. The severe skin rashes caused due to Lamivudine seen in our cases was observed between 7 to 11 days of starting antiretroviral therapy (ART) and re-exposure to Lamivudine triggered the reaction within 1–2 days.
Back to Top >>>>